Actively Recruiting

Phase 3
Age: 18Years +
All Genders
NCT07234162

A Phase 3 Multinational Study of Golidocitinib Versus Investigator's Choice in r/r PTCL (JACKPOT19)

Led by Dizal Pharmaceuticals · Updated on 2025-11-18

218

Participants Needed

50

Research Sites

233 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This is a phase 3, open-label, randomized, multinational study to evaluate the anti-tumor efficacy of golidocitinib versus investigator's choice in adult patients with relapsed/refractory peripheral T-cell lymphoma (r/r PTCL). This study will treat patients with pathologically confirmed PTCL who have relapsed after or been refractory/intolerant to at least one prior systemic treatment regimen(s).

CONDITIONS

Official Title

A Phase 3 Multinational Study of Golidocitinib Versus Investigator's Choice in r/r PTCL (JACKPOT19)

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Participants must sign the informed consent form and follow the study requirements
  • Age 18 years or older
  • ECOG performance status of 0 to 2 and expected to live at least 12 weeks
  • Histologically confirmed peripheral T-cell lymphoma of specific subtypes as per WHO classification
  • Disease has progressed, is refractory, or intolerant to at least one prior standard systemic therapy
  • Adequate bone marrow and organ function
  • Willingness to follow contraceptive requirements
Not Eligible

You will not qualify if you...

  • Previous or current treatments that are prohibited by the study protocol
  • Unresolved drug-related adverse events greater than grade 2
  • Lymphoma involving the central nervous system
  • Severe heart or lung problems
  • Conditions requiring immunosuppressants, biologics, or NSAIDs
  • Active infections
  • Any other cancer within the last five years
  • Poorly controlled gastrointestinal disorders or problems absorbing medication
  • Severe or poorly controlled systemic diseases

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 50 locations

1

Anhui Provincial Cancer Hospital

Hefei, Anhui, China, 230000

Actively Recruiting

2

The Second Hospital of Anhui Medical University

Hefei, Anhui, China, 230601

Actively Recruiting

3

Beijing Hospital

Beijing, Beijing Municipality, China, 100005

Actively Recruiting

4

Beijing Tongren Hospital, CMU

Beijing, Beijing Municipality, China, 100051

Actively Recruiting

5

Peking University Third Hospital

Beijing, Beijing Municipality, China, 100191

Actively Recruiting

6

The First Affiliated Hospital of Chongqing Medical University

Chongqing, Chongqing Municipality, China, 400016

Actively Recruiting

7

Fujian Cancer Hospital

Fuzhou, Fujian, China, 350011

Actively Recruiting

8

The First Affiliated Hospital of Xiamen University

Xiamen, Fujian, China, 361026

Actively Recruiting

9

The First Hospital of Lanzhou University

Lanzhou, Gansu, China, 730013

Actively Recruiting

10

Gansu Provincial Cancer Hospital

Lanzhou, Gansu, China, 730050

Actively Recruiting

11

Sun Yat-sen University Cancer Center

Guangzhou, Guangdong, China, 510060

Actively Recruiting

12

Guangdong Provincial People's Hospital

Guangzhou, Guangdong, China, 510210

Actively Recruiting

13

Guangxi Medical University Cancer Hospital

Nanning, Guangxi, China, 530200

Actively Recruiting

14

Harbin Medical University Cancer Hospital

Harbin, Heilongjiang, China, 150081

Actively Recruiting

15

Henan Cancer Hospital

Zhengzhou, Henan, China, 450008

Actively Recruiting

16

The First Affiliated Hospital of Zhengzhou University

Zhengzhou, Henan, China, 450052

Actively Recruiting

17

Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology

Wuhan, Hubei, China, 430030

Actively Recruiting

18

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Wuhan, Hubei, China, 430048

Actively Recruiting

19

Zhongnan Hospital of Wuhan University

Wuhan, Hubei, China, 430071

Actively Recruiting

20

Hubei Cancer Hospital

Wuhan, Hubei, China, 430079

Actively Recruiting

21

Hunan Cancer Hospital

Changsha, Hunan, China, 410013

Actively Recruiting

22

Nanjing Drum Tower Hospital

Nanjing, Jiangsu, China, 210008

Actively Recruiting

23

The First Bethune Hospital of Jilin University

Changchun, Jilin, China

Actively Recruiting

24

Shengjing Hospital of China Medical University

Shenyang, Liaoning, China, 110134

Actively Recruiting

25

Shandong Cancer Hospital & Institution

Jinan, Shandong, China, 250117

Actively Recruiting

26

Linyi Cancer Hospital

Linyi, Shandong, China, 276304

Actively Recruiting

27

Ruijin Hospital, Shanghai Jiaotong University School of Medicine

Shanghai, Shanghai Municipality, China, 200025

Actively Recruiting

28

Tongji Hospital of Tongji University

Shanghai, Shanghai Municipality, China, 200065

Actively Recruiting

29

Shanxi Provincial Cancer Hospital

Taiyuan, Shanxi, China, 30013

Actively Recruiting

30

The First Affiliated Hospital of Xi'an Jiaotong University

Xi’an, Shanxi, China, 710061

Actively Recruiting

31

Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital

Chengdu, Sichuan, China, 610072

Actively Recruiting

32

Tianjin Medical University Cancer Institute & Hospital

Tianjin, Tianjin Municipality, China, 300060

Actively Recruiting

33

The First Affiliated Hospital Zhejiang University School of Medicine

Hangzhou, Zhejiang, China, 310006

Actively Recruiting

34

Zhejiang Cancer Hospital

Hangzhou, Zhejiang, China, 310022

Actively Recruiting

35

Jinhua Municipal Centeral Hospital

Jinhua, Zhejiang, China, 321000

Actively Recruiting

36

The First Affiliated Hospital of Wenzhou Medical University

Wenzhou, Zhejiang, China, 325015

Actively Recruiting

37

Chang Bing Show Chwan Memorial Hospital

Changhua, Taiwan, 00505

Actively Recruiting

38

Kaohsiung Chang Gung Memorial Hospital

Kaohsiung City, Taiwan, 00833

Actively Recruiting

39

Taipei Medical University - Shuang Ho Hospital

New Taipei City, Taiwan, 23561

Actively Recruiting

40

China Medical University Hospital

Taichung, Taiwan, 40447

Actively Recruiting

41

Chi Mei Medical Center - Liouying Branch

Tainan, Taiwan, 00736

Actively Recruiting

42

National Cheng Kung University Hospital

Tainan, Taiwan, 70403

Actively Recruiting

43

National Taiwan University Hospital

Taipei, Taiwan, 10048

Actively Recruiting

44

Koo Foundation Sun Yat-Sen Cancer Center

Taipei, Taiwan, 11259

Actively Recruiting

45

King Chulalongkorn Memorial Hospital

Bangkok, Thailand, 10330

Actively Recruiting

46

Mahidol University - Faculty of Medicine - Ramathibodi Hospital

Bangkok, Thailand, 10400

Actively Recruiting

47

Phramongkutklao Hospital

Bangkok, Thailand, 10400

Actively Recruiting

48

Siriraj Hospital - Mahidol University

Bangkok, Thailand, 10700

Actively Recruiting

49

Maharaj Nakorn Chiang Mai Hospital

Chiang Mai, Thailand, 50200

Actively Recruiting

50

Prince of Songkla University-Faculty of Medicine

Hat Yai, Thailand, 90110

Actively Recruiting

Loading map...

Research Team

L

Ling Zhou

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

A Phase 3 Multinational Study of Golidocitinib Versus Investigator's Choice in r/r PTCL (JACKPOT19) | DecenTrialz